Quarterly report pursuant to Section 13 or 15(d)

Nature of Operations

v3.7.0.1
Nature of Operations
3 Months Ended
Mar. 31, 2017
Nature of Operations  
Nature of Operations

1.Nature of Operations

 

We were incorporated in the state of Delaware on June 14, 1996. We are engaged in the discovery and development of novel, targeted drug in the therapeutic areas of immunology, oncology and immuno-oncology.